Aptar Pharma has acquired the clinical trial materials manufacturing capabilities of Mod3 Pharma from SWK Holdings, according to a company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE